Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1978 Sep 23;2(6141):851–853. doi: 10.1136/bmj.2.6141.851

Low-cholesterol diet: enhancement of effect of CDCA in patients with gall stones.

D P Maudgal, R Bird, W S Blackwood, T C Northfield
PMCID: PMC1607974  PMID: 709092

Abstract

Fifteen patients with gall stones who were taking chenodeoxycholic acid(CDCA) 15 mg/kg at bedtime participated in two separate experiments to investigate the effects of altering sterol intake on the cholesterol saturation index (SI) of fasting gall-bladder bile. In experiment I the 15 patients on an unrestricted diet had a SI of 0.87 +/- 0.04 (mean +/- SE of mean), which fell to 0.75 +/- 0.04 after one week in hospital on a diet of 100 mg cholesterol daily. In experiment II seven of the patients were given four different dietary regimens lasting one month each in random order as outpatients. On a diet of 600 mg of cholesterol daily the mean SI was 0.72 +/- 0.05, which fell to 0.67 +/- 0.05 when the patients were put on a 100 mg cholesterol diet. The addition of plant sterols (3 g daily) to both diets raised the mean SIs to 0.80 +/- 0.05 and 0.77 +/- 0.05 respectively. The percentage CDCA in bile was unaffected by alterations in the cholesterol and plant sterol intakes. We conclude that a low-cholesterol diet but not a high intake of plant sterols enhances the effect of CDCA in patients with gall stones.

Full text

PDF
851

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adler R. D., Bennion L. J., Duane W. C., Grundy S. M. Effects of low dose chenodeoxycholic acid feeding on biliary lipid metabolism. Gastroenterology. 1975 Feb;68(2):326–334. [PubMed] [Google Scholar]
  2. BARTLETT G. R. Phosphorus assay in column chromatography. J Biol Chem. 1959 Mar;234(3):466–468. [PubMed] [Google Scholar]
  3. Bell G. D., Sutor D. J., Whitney B., Dowling R. Factors influencing human gallstone dissolution in monkey, dog, and human bile. Gut. 1972 Oct;13(10):836–836. [PubMed] [Google Scholar]
  4. Bell G. D., Whitney B., Dowling R. H. Gallstone dissolution in man using chenodeoxycholic acid. Lancet. 1972 Dec 9;2(7789):1213–1216. doi: 10.1016/s0140-6736(72)92266-0. [DOI] [PubMed] [Google Scholar]
  5. Coyne M. J., Bonorris G. G., Goldstein L. I., Schoenfield L. J. Effect of chenodeoxycholic acid and phenobarbital on the rate-limiting enzymes of hepatic cholesterol and bile acid synthesis in patients with gallstones. J Lab Clin Med. 1976 Feb;87(2):281–291. [PubMed] [Google Scholar]
  6. Grundy S. M., Ahrens E. H., Jr, Davignon J. The interaction of cholesterol absorption and cholesterol synthesis in man. J Lipid Res. 1969 May;10(3):304–315. [PubMed] [Google Scholar]
  7. Haslewood G. A., Murphy G. M., Richardson J. M. A direct enzymic assay for 7 -hydroxy bile acids and their conjugates. Clin Sci. 1973 Jan;44(1):95–98. doi: 10.1042/cs0440095. [DOI] [PubMed] [Google Scholar]
  8. Hegardt F. G., Dam H. The solubility of cholesterol in aqueous solutions of bile salts and lecithin. Z Ernahrungswiss. 1971 Apr;10(3):223–233. doi: 10.1007/BF02020933. [DOI] [PubMed] [Google Scholar]
  9. Holzbach R. T., Marsh M., Olszewski M., Holan K. Cholesterol solubility in bile. Evidence that supersaturated bile is frequent in healthy man. J Clin Invest. 1973 Jun;52(6):1467–1479. doi: 10.1172/JCI107321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Iser J. H., Dowling H., Mok H. Y., Bell G. D. Chenodeoxycholic acid treatment of gallstones. A follow-up report and analysis of factors influencing response to therapy. N Engl J Med. 1975 Aug 21;293(8):378–383. doi: 10.1056/NEJM197508212930804. [DOI] [PubMed] [Google Scholar]
  11. Iser J. H., Maton P. N., Murphy G. M., Dowling R. H. Resistance to chenodeoxycholic acid (CDCA) treatment in obese patients with gall stones. Br Med J. 1978 Jun 10;1(6126):1509–1512. doi: 10.1136/bmj.1.6126.1509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Iser J. H., Murphy G. M., Dowling R. H. Speed of change in biliary lipids and bile acids with chenodeoxycholic acid--is intermittent therapy feasible? Gut. 1977 Jan;18(1):7–15. doi: 10.1136/gut.18.1.7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Northfield T. C., LaRusso N. F., Hofmann A. F., Thistle J. L. Biliary lipid output during three meals and an overnight fast. II. Effect of chenodeoxycholic acid treatment in gallstone subjects. Gut. 1975 Jan;16(1):12–17. doi: 10.1136/gut.16.1.12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Thistle J. L., Hofmann A. F. Efficacy and specificity of chenodeoxycholic acid therapy for dissolving gallstones. N Engl J Med. 1973 Sep 27;289(13):655–659. doi: 10.1056/NEJM197309272891303. [DOI] [PubMed] [Google Scholar]
  15. Thomas P. J., Hofmann A. F. Letter: A simple calculation of the lithogenic index of bile: expressing biliary lipid composition on rectangular coordinates. Gastroenterology. 1973 Oct;65(4):698–700. [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES